MEDLEMSNYHET - Although the above statement is intentionally somewhat provocative, it does hold a degree of truth.
As transparency and consistency become increasingly emphasized by the FDA, medical device manufacturers must approach their submissions with both thoroughness and coherence. Successfully navigating ...
MEDLEMSNYHET - ISO 10993-1, the core standard for the biological evaluation of medical devices, has been under revision over ...
Since 2022, Ingpuls GmbH, based in Bochum, Germany, has been producing ultra-thin Nitinol wires for stents. To ensure the ...
FDA’s final guidance on Computer Software Assurance (CSA) for Production and Quality System Software marks a significant modernization of software validation practices. In late September, the FDA ...
In an industry shaped by rapid regulatory changes and global competition, leading life science companies are rethinking what it takes to succeed. Increasingly, expert support is no longer a ...
This year we will host a series of events. Starting in November 2025, local events called ZEISS QUALITY INNOVATIONS WORLDWIDE will take place. The idea: We are bringing the event series to your region ...
Antalet anställda och antalet företag inom svensk life science ökar och sektorn är mer jämställd än många andra sektorer. Men ...
Ingen på Novo Nordisks svenska marknadsbolag berörs av den tidigare aviserade uppsägningarna på 9 000 anställda, uppger ...
Svenska Medivir har ingått ett licenssamarbete med kanadensiska Biossil för fortsatt utveckling av Remetinostat, ett ...
Från att tidigare ha verkat i det dolda har kriminella nätverk nu flyttat handeln med förfalskade läkemedel ut i det öppna på ...
Sara Lowemark har sedan mitten av augusti rollen som chef för internationella relationer på Lif – de forskande ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback